Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

about

Infection: a Cause of and Cure for Cancer.The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

P2860

Q47142729-A53FA2A1-FD93-432A-8926-486931E233A6 Q52594999-505F876B-BAE6-4898-8383-77A24C5BA5A1 Q57192791-D348CF7D-FF50-4EF8-A738-545A7404CB74

P2860

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

Item

http://www.wikidata.org/entity/Q41684403

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

@en

type

Item

label

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

@en

prefLabel

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

@en

P1476

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies

@en

P2093

Aditya Thandoni

http://www.w3.org/2001/XMLSchema#string

Ann W Silk

http://www.w3.org/2001/XMLSchema#string

Frederick J Kohlhapp

http://www.w3.org/2001/XMLSchema#string

Praveen K Bommareddy

http://www.w3.org/2001/XMLSchema#string

Sachin R Jhawar

http://www.w3.org/2001/XMLSchema#string

Sharad Goyal

http://www.w3.org/2001/XMLSchema#string

Suemair Hassan

http://www.w3.org/2001/XMLSchema#string

P2860

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells

Oncolytic viruses as immunotherapy: progress and remaining challenges

Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.

P304

202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2017.00202

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Zloza

Jason M Schenkel

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28955655

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5600978

http://www.w3.org/2001/XMLSchema#string

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

about

P2860

P2860

Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932